fingolimod hydrochloride has been researched along with Berberine chloride (TN) in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (Berberine chloride (TN)) | Trials (Berberine chloride (TN)) | Recent Studies (post-2010) (Berberine chloride (TN)) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 106 | 0 | 56 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | Berberine chloride (TN) (IC50) |
|---|---|---|---|
| sentrin-specific protease 8 | Homo sapiens (human) | 7.66 | |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.712 | |
| Cell division protein FtsZ | Escherichia coli K-12 | 10 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 4.5042 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 3.08 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.601 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 2.837 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.4747 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.374 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.374 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.437 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.374 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1 | |
| Serine/threonine-protein kinase Nek7 | Homo sapiens (human) | 4.2 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.289 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, ZX; Han, Q; Li, YH; Tang, HZ; Wang, L; Zhao, J; Zou, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and Berberine chloride (TN)
| Article | Year |
|---|---|
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Cell Line, Tumor; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Drug Therapy, Combination; Fingolimod Hydrochloride; Male; Mice; Molecular Docking Simulation; Molecular Structure; Recurrence; Sphingosine-1-Phosphate Receptors; Spleen; STAT3 Transcription Factor | 2020 |